TABLE 1

Univariate Analysis for Glut-1 or SUV1

Parameter	Glut-1			SUV1
Parameter		Primary	Recurrent or persistent	Primary	Recurrent or persistent
Age	0.005*	−0.317*	0.079*	−0.279*
P	0.980	0.114	0.706	0.168
Differentiation (initial)
Well to moderate	1.58 ± 0.41^†	1.21 ± 0.71^†	15.56 ± 5.59^†	9.17 ± 5.21^†
n	12	15	12	15
Poor	1.31 ± 0.63^†	1.17 ± 0.83^†	14.96 ± 7.56^†	9.64 ± 10.65^†
n	13	11	13	11
P	0.101	0.660	0.378	0.286
FIGO (initial)
≤IIA	1.33 ± 0.50^†	1.07 ± 0.74^†	11.44 ± 5.39^†	9.12 ± 9.59^†
n	8	14	8	14
≥IIB	1.50 ± 0.56^†	1.33 ± 0.77^†	17.04 ± 6.41^†	9.67 ± 5.38^†
n	17	12	17	12
P	0.771	0.505	0.099	0.326
Size	0.338*	0.508*	0.253*	0.456*
P	0.114	0.011	0.244	0.025
Site
Main	1.45 ± 0.55^†	1.39 ± 0.76^†	15.76 ± 6.17^†	12.99 ± 10.40^†
n	24	11	24	11
Lymph node	1.20	0.91 ± 0.56^†	2.98	6.03 ± 2.58^†
n	1	14	1	14
Colon	—	2.85	—	16.34
n	0	1	0	1
P	—	0.121^‡	—	0.0226^‡

↵* Pearson correlation coefficient.
↵^† Mean ± SD.
↵^‡ Comparison between main tumor and lymph node.
SUV1 = SUV at 40 min after injection.
P values were computed using either Wilcoxon rank sum test or Kruskal–Wallis test or t test.